Barcelona, Spain

Daniel Perez Crespo

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Perez Crespo

Introduction

Daniel Perez Crespo is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address inflammatory and allergic diseases. His work exemplifies the intersection of scientific research and practical application in medicine.

Latest Patents

Daniel Perez Crespo holds a patent for "Tricyclic derivatives as LTD4 antagonists." This patent includes compounds of formula (I) and their pharmaceutically acceptable salts. The compounds are designed to be useful in the treatment or prevention of inflammatory and allergic diseases. His innovative approach in this area highlights the potential for new therapeutic options.

Career Highlights

Throughout his career, Crespo has worked with prominent companies in the pharmaceutical industry, including Laboratorios Almirall, S.A. and Almirall, S.A. His experience in these organizations has allowed him to contribute to significant advancements in drug development and research.

Collaborations

Crespo has collaborated with esteemed colleagues such as Carlos Puig Duran and Jordi Bach Tana. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.

Conclusion

Daniel Perez Crespo's work in developing pharmaceutical compounds demonstrates his commitment to addressing critical health issues. His contributions to the field of medicine through his patent and collaborations with industry professionals underscore the importance of innovation in improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…